Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsResearchers showed that engineering of a medium-length CAR spacer enhances the therapeutic efficacy of human erb-b2 receptor tyrosine kinase 2 (HER2)-specific CAR T cells in an orthotopic xenograft medulloblastoma model.
[Nature Medicine]
6445218 D3DEKXVS items 1 apa 0 default asc 1 164459 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-b520e57d329622f1db63d00d260e0e3e%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22D3DEKXVS%22%2C%22library%22%3A%7B%22id%22%3A6445218%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Vitanza%20et%20al.%22%2C%22parsedDate%22%3A%222021-07-12%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EVitanza%2C%20N.%20A.%2C%20Johnson%2C%20A.%20J.%2C%20Wilson%2C%20A.%20L.%2C%20Brown%2C%20C.%2C%20Yokoyama%2C%20J.%20K.%2C%20K%26%23xFC%3Bnkele%2C%20A.%2C%20Chang%2C%20C.%20A.%2C%20Rawlings-Rhea%2C%20S.%2C%20Huang%2C%20W.%2C%20Seidel%2C%20K.%2C%20Albert%2C%20C.%20M.%2C%20Pinto%2C%20N.%2C%20Gust%2C%20J.%2C%20Finn%2C%20L.%20S.%2C%20Ojemann%2C%20J.%20G.%2C%20Wright%2C%20J.%2C%20Orentas%2C%20R.%20J.%2C%20Baldwin%2C%20M.%2C%20Gardner%2C%20R.%20A.%2C%20%26%23x2026%3B%20Park%2C%20J.%20R.%20%282021%29.%20Locoregional%20infusion%20of%20HER2-specific%20CAR%20T%20cells%20in%20children%20and%20young%20adults%20with%20recurrent%20or%20refractory%20CNS%20tumors%3A%20an%20interim%20analysis.%20%3Ci%3ENature%20Medicine%3C%5C%2Fi%3E%2C%201%26%23x2013%3B9.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41591-021-01404-8%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41591-021-01404-8%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445218%26amp%3Bitem_key%3DD3DEKXVS%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Locoregional%20infusion%20of%20HER2-specific%20CAR%20T%20cells%20in%20children%20and%20young%20adults%20with%20recurrent%20or%20refractory%20CNS%20tumors%3A%20an%20interim%20analysis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicholas%20A.%22%2C%22lastName%22%3A%22Vitanza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%20J.%22%2C%22lastName%22%3A%22Johnson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ashley%20L.%22%2C%22lastName%22%3A%22Wilson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%22%2C%22lastName%22%3A%22Brown%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jason%20K.%22%2C%22lastName%22%3A%22Yokoyama%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Annette%22%2C%22lastName%22%3A%22K%5Cu00fcnkele%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cindy%20A.%22%2C%22lastName%22%3A%22Chang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephanie%22%2C%22lastName%22%3A%22Rawlings-Rhea%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wenjun%22%2C%22lastName%22%3A%22Huang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kristy%22%2C%22lastName%22%3A%22Seidel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20M.%22%2C%22lastName%22%3A%22Albert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Navin%22%2C%22lastName%22%3A%22Pinto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juliane%22%2C%22lastName%22%3A%22Gust%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%20S.%22%2C%22lastName%22%3A%22Finn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%20G.%22%2C%22lastName%22%3A%22Ojemann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jason%22%2C%22lastName%22%3A%22Wright%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rimas%20J.%22%2C%22lastName%22%3A%22Orentas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Baldwin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rebecca%20A.%22%2C%22lastName%22%3A%22Gardner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20C.%22%2C%22lastName%22%3A%22Jensen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julie%20R.%22%2C%22lastName%22%3A%22Park%22%7D%5D%2C%22abstractNote%22%3A%22Locoregional%20delivery%20of%20chimeric%20antigen%20receptor%20%28CAR%29%20T%20cells%20has%20resulted%20in%20objective%20responses%20in%20adults%20with%20glioblastoma%2C%20but%20the%20feasibility%20and%20tolerability%20of%20this%20approach%20is%20yet%20to%20be%20evaluated%20for%20pediatric%20central%20nervous%20system%20%28CNS%29%20tumors.%20Here%20we%20show%20that%20engineering%20of%20a%20medium-length%20CAR%20spacer%20enhances%20the%20therapeutic%20efficacy%20of%20human%20erb-b2%20receptor%20tyrosine%20kinase%202%20%28HER2%29-specific%20CAR%20T%20cells%20in%20an%20orthotopic%20xenograft%20medulloblastoma%20model.%20We%20translated%20these%20findings%20into%20BrainChild-01%20%28NCT03500991%29%2C%20an%20ongoing%20phase%201%20clinical%20trial%20at%20Seattle%20Children%5Cu2019s%20evaluating%20repetitive%20locoregional%20dosing%20of%20these%20HER2-specific%20CAR%20T%20cells%20to%20children%20and%20young%20adults%20with%20recurrent%5C%2Frefractory%20CNS%20tumors%2C%20including%20diffuse%20midline%20glioma.%20Primary%20objectives%20are%20assessing%20feasibility%2C%20safety%20and%20tolerability%3B%20secondary%20objectives%20include%20assessing%20CAR%20T%20cell%20distribution%20and%20disease%20response.%20In%20the%20outpatient%20setting%2C%20patients%20receive%20infusions%20via%20CNS%20catheter%20into%20either%20the%20tumor%20cavity%20or%20the%20ventricular%20system.%20The%20initial%20three%20patients%20experienced%20no%20dose-limiting%20toxicity%20and%20exhibited%20clinical%2C%20as%20well%20as%20correlative%20laboratory%2C%20evidence%20of%20local%20CNS%20immune%20activation%2C%20including%20high%20concentrations%20of%20CXCL10%20and%20CCL2%20in%20the%20cerebrospinal%20fluid.%20This%20interim%20report%20supports%20the%20feasibility%20of%20generating%20HER2-specific%20CAR%20T%20cells%20for%20repeated%20dosing%20regimens%20and%20suggests%20that%20their%20repeated%20intra-CNS%20delivery%20might%20be%20well%20tolerated%20and%20activate%20a%20localized%20immune%20response%20in%20pediatric%20and%20young%20adult%20patients.%22%2C%22date%22%3A%222021-07-12%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41591-021-01404-8%22%2C%22ISSN%22%3A%221546-170X%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fs41591-021-01404-8%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-07-12T18%3A19%3A54Z%22%7D%7D%5D%7D
Vitanza, N. A., Johnson, A. J., Wilson, A. L., Brown, C., Yokoyama, J. K., Künkele, A., Chang, C. A., Rawlings-Rhea, S., Huang, W., Seidel, K., Albert, C. M., Pinto, N., Gust, J., Finn, L. S., Ojemann, J. G., Wright, J., Orentas, R. J., Baldwin, M., Gardner, R. A., … Park, J. R. (2021). Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis. Nature Medicine, 1–9. https://doi.org/10.1038/s41591-021-01404-8 Cite
